Helene Highbarger

Statistics

Publications

Citations

349

H-Index

Active since

2013

Affiliations

Frederick National Laboratory for Cancer Research(Current)

National Institute of Allergy and Infectious Diseases

Baylor College of Medicine

National Institutes of Health

University of Colorado Denver

Helene Highbarger is an author at Frederick National Laboratory for Cancer Research specializing in infectious diseases, pharmacy, and pharmacotherapy.

Publications per year

2013–2024

Publications

Sofosbuvir and Ribavirin for Hepatitis C Genotype 1 in Patients With Unfavorable Treatment Characteristics

A. Osinusi, Eric G. Meissner, Y.-J. Lee et al. · JAMA · 2013 · 287 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial

Samuel M. Brown, Christina E. Barkauskas, Birgit Grund et al. · The Lancet Respiratory Medicine · 2023 · 19 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +13

Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19

Neil R. Aggarwal, Jacquie Nordwall, Dominique L. Braun et al. · Clinical Infectious Diseases · 2024 · 16 citations · Full text

Life Sciences, Immunology, Infectious Diseases +15

Natural Occurring Polymorphisms in HIV-1 Integrase and RNase H Regulate Viral Release and Autoprocessing

Tomozumi Imamichi, John G. Bernbaum, Sylvain Laverdure et al. · Journal of Virology · 2021 · 14 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

SARS-CoV-2 RNA and Nucleocapsid Antigen Are Blood Biomarkers Associated With Severe Disease Outcomes That Improve in Response to Remdesivir

Kanal Singh, Kevin Rubenstein, Viviane Callier et al. · The Journal of Infectious Diseases · 2024 · 13 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

1–5 of 5